New Key Statistics Module, Z-Score and F-Score
NAS:ATYR Key Ratios
| Market Cap $ M | 287.08 |
| Enterprise Value $ M | 234.48 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.98 |
| Price/Sales | 855.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.94 |
| Beneish M-Score | 24.75 |
| 10-y EBITDA Growth Rate % | 33.90 |
| 5-y EBITDA Growth Rate % | 39.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.45 |
| EV-to-EBITDA | -3.55 |
| PEG | -- |
| Shares Outstanding M | 83.94 |
| Net Margin (%) | -27,155.75 |
| Operating Margin % | -28,958.72 |
| Pre-tax Margin (%) | -27,155.32 |
| Quick Ratio | 5.41 |
| Current Ratio | 5.41 |
| ROA % (ttm) | -57.33 |
| ROE % (ttm) | -75.89 |
| ROIC % (ttm) | -383.23 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.88 |
ATYR Number of Guru Trades
ATYR Volume of Guru Trades
Gurus Latest Trades with NAS:ATYR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ATYR is held by these investors
Total 1
aTyr Pharma Inc Insider Transactions
No Available Data
News about NAS:ATYR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers